Ranked by MELANY · Oct 2026
Robotics and Automation Stocks, Rated
Robotics spans surgical systems, factory automation, warehouse and logistics robots, machine vision and the chip and software layers underneath. Most listed exposure comes through diversified industrial and technology companies rather than pure plays.
Every score on this page is free. 17 robotics and automation stocks scored on the same eight factors, updated as the data changes.
MELANY rankingRatings as of 2026-10-07Robotics and Automation Stocks
Ranked by composite score
Ranked highest to lowest by MELANY composite score, a 0 to 100 reading from eight factors. Each row links to the full breakdown and the live price. Ratings are a dated snapshot, most recently computed 2026-10-07.
These tiers are algorithmic research readings, not a recommendation to buy or sell any security, and not personalized investment advice. Ranking order is not a suggested purchase order.
What is in the app for these 17 companies
The score and the eight factors behind it are open on every company page. The trade plan is the part that is not: one suggested entry price per company, the stop, the targets, and an alert when a name enters its entry zone. That is part of Market Eyes Pro, and the first 30 days are free.
What moves this group
Industrial capital spending sets the pace for the automation names, so this group tracks manufacturing activity and the cost of capital closely. Labour costs are the structural tailwind: automation demand tends to rise when wages do. Surgical and medical robotics follow procedure volumes and hospital budgets, which is a different cycle entirely.
Also searched as: robotics stocks, industrial automation companies, warehouse robotics shares.
How Market Eyes Live scores these companies
Every company on this page is scored by MELANY, our own engine, which reads regulatory filings and market data and produces a composite score from 0 to 100 across eight factors: valuation, business quality, price momentum, earnings track record, analyst sentiment, catalyst setup, risk-adjusted profile and macro fit.
Each score maps to a conviction tier rather than a buy or sell call. Established companies with enough financial history are judged on fundamentals. Pre-profit or thin-data companies are judged on a separate speculative path that leans on momentum and theme strength, because there are not enough fundamentals to read. That is why two names with similar scores can carry very different risk.
The engine is not new to being tested. MELANY's risk and portfolio rules are stress-tested across 19 years of U.S. market history, from 2007 to 2026, spanning the 2008 financial crisis, the 2020 COVID crash and the 2022 bear market, and the test set includes companies that later delisted so the results are not flattered by survivorship. Every rating it publishes is also recorded and graded every day against what the market does next. The full methodology and the validation study are public: how MELANY is tested and the MELANY validation study, Working Paper No. 01.
Frequently asked questions
Are there pure-play robotics stocks?
Few of any size. Most of the listed exposure sits inside diversified industrial and technology companies, which is why this list includes them.
What drives robotics demand?
Industrial capital spending and labour costs. Automation investment tends to accelerate when wages rise and slow when capital is expensive.
How should I read the conviction tier?
It is the plain-language summary of where a name sits in our eight-tier ladder. The composite score and the factor breakdown show why.
Other sectors and themes
Market Eyes Live
The scores stay free. The entry prices are in Pro, 30 days free.
MELANY rates every U.S. stock and ETF, PRISM ranks conviction and APEX writes the plan with one entry zone. Every rating is graded in public.